Journal
DIABETES CARE
Volume 35, Issue 4, Pages 803-808Publisher
AMER DIABETES ASSOC
DOI: 10.2337/dc11-1955
Keywords
-
Categories
Funding
- National Science Council (NSC) [100-2811-B-010-001-MY3]
- Taipei Veterans General Hospital [V100C-143, V100E4-003, V99C1-158]
- Bureau of Health Promotion
- Department of Health [DOH98-HP-1110]
- Ministry of Education
Ask authors/readers for more resources
OBJECTIVE-The current study aimed to investigate whether microalbuminuria or moderately decreased glomerular filtration rate (GFR) is a better predictor for the development and progression of retinopathy in type 2 diabetic patients. RESEARCH DESIGN AND METHODS Type 2 diabetic patients without cardiovascular diseases, malignancy, pregnancy, and acute intercurrent illness were enrolled between 1 August 2001 and 31 December 2002. All participants provided their detailed medical history and underwent an eye fundus examination. They were followed up in outpatient clinics, and serum creatinine, urinary albumin-to-creatinine ratio (UACR), and retinal photographs were followed up annually until 31 December 2009. The primary outcomes were development and progression of diabetic retinopathy and nephropathy. The secondary outcomes were cardiovascular events and all-cause mortality. RESULTS Among 487 participants, 81 subjects had normoalbuminuria and moderate renal impairment (baseline eGFR 30-59.9 mL/min/1.73 m(2)), and 106 subjects had microalbuminuria and baseline eGFR >= 60 mL/min/1.73 m(2). Patients with microalbuminuria and eGFR >= 60 mL/min/1.73 m(2) had a significantly greater risk for development and progression of diabetic retinopathy (HR 3.34 [95% CI 1.04-10.70]) compared with those with moderate renal impairment and normoalbuminuria after multivariate adjustment. Risks for renal outcome, cardiovascular events, and all-cause mortality were not significantly different between the two groups. CONCLUSIONS-Microalbuminuria has a greater impact on predicting the development and progression of diabetic retinopathy compared with moderate decline in GFR among type 2 diabetic patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available